John R. Moore, VP, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 2,959 shares at $3.30 ($10K) on 2011-01-11, disclosed to the SEC on 2011-01-12.
Scheduled sale ($10k) by VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.30 | 593 | $2K | 20.0% |
| 2 | $3.30 | 2,366 | $8K | 80.0% |
| Total | $3.30 avg | 2,959 | $10K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |